646
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Vesicles: Potential nano carriers for the delivery of skin cosmetics

ORCID Icon & ORCID Icon
Pages 485-493 | Received 09 Jun 2016, Accepted 17 Jul 2017, Published online: 05 Sep 2017

References

  • Gupta PN, Singh P, Mishra V. Topical immunization: mechanistic insight and novel drug delivery. Ind J Biotech. 2003;3:9–21.
  • Singh D, Pradhan M, Nag M, Singh MR. Vesicular system: Versatile carrier for transdermal delivery of bioactives. Artif Cells Nanomed Biotechnol. 2015;43(4):282–90. doi:10.3109/21691401.2014.883401.
  • Strauss G. Liposomes: From theoretical model to cosmetic tool. J Soc Cosmet Chem. 1989;40:51–60.
  • Maghraby EI, Barry GM, Williams BW, Adrian C. Liposomes and skin: From drug delivery to model membranes. Eur J Pharm Sci. 2008;34:203–22. doi:10.1016/j.ejps.2008.05.002.
  • Chang C, Shan-Shan T, Ying X. Proliposomes for oral delivery of dehydrosilymarin: Preparation and evaluation in vitro and in vivo. Acta Pharmacologica Sinica. 2011;32:973–80. doi:10.1038/aps.2011.25.
  • Hwang BY, Jung BH, Chung SJ, Lee MH, Shim CK. In vitro skin permeation of nicotine from proliposomes. J Control Rel. 1997;49:177–84. doi:10.1016/S0168-3659(97)00073-4.
  • Hamishehkar H, Rahimpour Y, Kouhsoltani M. Niosomes as a propitious carrier for topical drug delivery. Expert Opin Drug Deliv. 2013;10(2):261–72. doi:10.1517/17425247.2013.746310.
  • Ozer AY, Hinchal AA, Bouwstra JA. Novel drug delivery system non-ionic surfactant vesicles. Eur J Pharm Biopharm. 1991;37:75–79.
  • Jain S, Jain P, Umamaheshwari RB, Jain NK. Transferosomes – a novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation. Drug Dev Ind Pharm. 2003;29:1013–26. doi:10.1081/DDC-120025458.
  • Arora S, Lamba HS, Tiwari R. Dermal delivery of drugs using different vesicular carriers: A comparative review. Asian J Pharm. 2012;6:237–44. doi:10.4103/0973-8398.107558.
  • Pandey V, Golhani D, Shukla R. Ethosomes: Versatile vesicular carriers for efficient transdermal delivery of therapeutic agents. Drug Del. 2015;22(8):988–1002. doi:10.3109/10717544.2014.889777.
  • Amit G, Ashawat MS, Shailendra S, Swarnlata S. Phytosome: A novel approach towards functional cosmetics. J Plant Sci. 2007;2:644–49. doi:10.3923/jps.2007.644.649.
  • Jain SS, Jagtap PS, Dand NM, Jadhav KR, Kadam VJ. Aquasomes: A novel drug carrier. J App Pharm Sci. 2012;2:184–92.
  • Pang KS, Liu L, Sun H. Interaction of drug transporters with excipients, in role of lipid excipients. In: Wasan KM, editor. Modifying oral and parenteral drug delivery: basic principles and biological examples. Hoboken NJ, USA: John Wiley & Sons, Inc.; 2006.
  • Bhumika S, Arvind S. Future prospect of nanotechnology in development of anti-ageing formulation. Int J Pharm Pharm Sci. 2012;4:57–66.
  • Romero EL, Morilla MJ. Highly deformable and highly fluid vesicles as potential drug delivery system: Theoretical and practical considerations. Int J Nanomed. 2013;8:3171–86. doi:10.2147/IJN.S33048.
  • Kumar D, Singh D, Singh G, Singh M, Rathor MR. Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN Pharm. 2012;1–11. doi:10.5402/2012/941068.
  • Loo C, Basri M, Ismail R. Effect of compositions in nanostructured lipid carriers (NLC) on skin hydration and occlusion. Int J Nanomed. 2013;8:13–22.
  • Malaekeh NB, Golmohammadzadeh S, Salmani CS, Mosallaei N, Jamialahmadi K. Preparation, characterization, and moisturizing effect of liposomes containing glucosamine and N-acetyl glucosamine. J Cosmet Dermatol. 2013;12(2):96–102. doi:10.1111/jocd.2013.12.issue-2.
  • Manca ML, Matricardi P, Cencetti C, Peris JE, Melis V, Carbone C, Escribano E, Zaru M, Fadda AM, Manconi M. Combination of argan oil and phospholipids for the development of an effective liposome-like formulation able to improve skin hydration and allantoin dermal delivery. Int J Pharm. 2016;505:204–11. doi:10.1016/j.ijpharm.2016.04.008.
  • Du C, Anderson A, Lortie M, Parsons R, Bodnar A. Oxidative damage and cellular defense mechanisms in sea urchin models of aging. Free Radic Biol Med. 2013;63:254–63. doi:10.1016/j.freeradbiomed.2013.05.023.
  • Sharma VK, Sarwa KK, Mazumder B. Fluidity enhancement: A critical factor for performance of liposomal transdermal drug delivery system. J Liposome Res. 2014;24(2):83–89. doi:10.3109/08982104.2013.847956.
  • Jeswani G, Swarnlata S. Topical delivery of Curcuma longa extract loaded nanosized ethosomes to combat facial wrinkles. J Pharm Drug Deliv Res. 2014;1:2.
  • Manca ML, Castangia I, Zaru M, Nácher A, Valenti D, Fernàndez-Busquets X, Fadda AM, Manconi M. Development of curcumin loaded sodium hyaluronate immobilized vesicles (hyalurosomes) and their potential on skin inflammation and wound restoring. Biomaterials. 2015;71:100–09. doi:10.1016/j.biomaterials.2015.08.034.
  • Castangia I, Caddeo C, Manca ML, Casu L, Latorre AC, Díez-Sales O, Ruiz-Saurí A, Bacchetta G, Fadda AM, Manconi M. Delivery of liquorice extract by liposomes and hyalurosomes to protect the skin against oxidative stress injuries. Carbohydr Polym. 2015;10(134):657–63. doi:10.1016/j.carbpol.2015.08.037.
  • Shen LN, Zhang YT, Wang Q, Xu L, Feng NP. Enhanced in vitro and in vivo skin deposition of apigenin delivered using ethosomes. Int J Pharm. 2014;460:280–88. doi:10.1016/j.ijpharm.2013.11.017.
  • Yadav NK, Nanda S, Sharma G, Katare OP. Systematically optimized coenzymeQ10-loaded novel proniosomal formulation for treatment of photo-induced aging in mice: characterization, biocompatibility studies, biochemical estimations and anti-aging evaluation. J Drug Target. 2016;24(3):257–71. doi:10.3109/1061186X.2015.1077845.
  • Maramaldi G, Togni S, Pagin I, Giacomelli L, Cattaneo R, Eggenhoffner R, Burastero SE. Soothing and anti-itch effect of quercetin phytosome in human subjects: A single-blind study. Clin Cosmet Investig Dermatol. 2016;9:55–62. doi:10.2147/CCID.S98890.
  • Heydari S, Ghanbarzadeh S, Anoush B, Ranjkesh M, Javadzadeh Y, Kouhsoltani M, Hamishehkar H. Nanoethosomal formulation of gammaoryzanol for skin-aging protection and wrinkle improvement: A histopathological study. Drug Dev Ind Pharm. 2017;43(7):1154–62. doi:10.1080/03639045.2017.1300169.
  • Avadhani KS, Manikkath J, Tiwari M, Chandrasekhar M, Godavarthi A, Vidya SM, Hariharapura RC, Kalthur G, Udupa N, Mutalik S. Skin delivery of epigallocatechin-3-gallate (EGCG) and hyaluronic acid loaded nano-transfersomes for antioxidant and anti-aging effects in UV radiation induced skin damage. Drug Del. 2017;24(1):61–74. doi:10.1080/10717544.2016.1228718.
  • Celia C, Cilurzo F, Trapasso E, Cosco D, Fresta M, Paolino D. Ethosomes® and transfersomes® containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders. Biomed Microdevices. 2012;14(1):119–30. doi:10.1007/s10544-011-9590-y.
  • Banihashemi M, Zabolinejad N, Jaafari MR, Salehi M, Jabari A. Comparison of therapeutic effects of liposomal tranexamic acid and conventional hydroquinone on melasma. J Cosmet Dermatol. 2015;14(3):174–77. doi:10.1111/jocd.12152.
  • Lee MH, Lee KK, Park MH, Hyun SS, Kahn SY, Joo KS, Kang HC, Kwon WT. Anti-melanogenesis activity and skin permeability of niacinamide-loaded flexible liposomes (Bounsphere™). J Drug Deliv Sci Technol. 2016;147–52. doi:10.1016/j.jddst.2015.12.008.
  • Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 2007;123(2):148–54. doi:10.1016/j.jconrel.2007.08.005.
  • Zidan AS, Mokhtar IM, Megrab NA. Optimization of methotrexate loaded niosomes by Box–Behnken design: an understanding of solvent effect and formulation variability. Drug Dev Ind Pharm. 2017;26:1–10.
  • Sindhu D, Jain A, Chopra DK, Khan W. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci. 2017;96:515–29. doi:10.1016/j.ejps.2016.10.025.
  • Zhang YT, Shen LN, Zhao JH, Feng NP. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis. Int J Nanomedicine. 2014;9:669–78. doi:10.2147/IJN.S57314.
  • Shigetoshi S. Psoriasis as a barrier disease. Dermatologica Sinica. 2015;33:64–69. doi:10.1016/j.dsi.2015.04.010.
  • Abdelgawad R, Nasr M, Moftah NH, Hamza MY. Phospholipid membrane tabulation using ceramide doping “Cerosomes”: Characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 2017;101:258–68. doi:10.1016/j.ejps.2017.02.030.
  • Kassem AA, Abd El-Alim SH, Asfour MH. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm. 2017;517(1–2):256–68. doi:10.1016/j.ijpharm.2016.12.018.
  • Jamin C. Androgenetic alopecia. Ann Dermatol Venereol. 2002;129(5 Pt2):801–03.
  • Antonio JR, Antônio CR, Cardeal ILS, Ballavenuto JMA, Oliveira JR. Nanotechnology in Dermatology. An Bras Dermatol. 2014;89(1):126–36. doi:10.1590/abd1806-4841.20142228.
  • Noor NM, Sheikh K, Somavarapu S, Taylor KM. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Eur J Pharm Biopharm. 2017;S0939-6411(17):30457–5.
  • Yazdani-Arazi SN, Ghanbarzadeh S, Adibkia K, Kouhsoltani M, Hamishehkar H. Histological evaluation of follicular delivery of arginine via nanostructured lipid carriers: A novel potential approach for the treatment of alopecia. Artif Cells Nanomed Biotechnol. 2016;31:1–9. doi:10.1080/21691401.2016.1241794.
  • Aljuffali IA, Sung CT, Shen FM, Huang CT, Fang JY. Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells. AAPS J. 2014;16(1):140–50. doi:10.1208/s12248-013-9550-y.
  • Rani D, Singh C, Kumar A, Sharma VK. Formulation development and in-vitro evaluation of minoxidil bearing glycerosomes. Am J Biomed Res. 2016;4:27–37.
  • Patel N, Panda S. Liposome drug delivery system: A critic review. J Pharm Sci Bio-Sci Res. 2012;2:169–75.
  • Brant J, Lecoanet H, Wiesner MR. Aggregation and deposition characteristics of fullerene nanoparticles in aqueous systems. J Nanopart Res. 2005;7:545–53. doi:10.1007/s11051-005-4884-8.
  • Hua S, Wu SYT. The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol. 2013;21:143.
  • Storm G, Oussoren C, Peters PAM, Barenholz Y. Tolerability of liposomes in vivo. In Gregoriadis G, editors. Liposome technology. Florida, Boca Raton: CRC Press; 1992. pp. 345–83.
  • Paolino D, Lucania G, Mardente D. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Cont Rel. 2005;106:99–110. doi:10.1016/j.jconrel.2005.04.007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.